HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying-Syuan Li Selected Research

NDI-091143

10/2022ACLY inhibitors induce apoptosis and potentiate cytotoxic effects of sorafenib in thyroid cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying-Syuan Li Research Topics

Disease

4Thyroid Neoplasms (Thyroid Cancer)
10/2022 - 08/2019
1Neoplasms (Cancer)
10/2022
1Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2018
1Psychotic Disorders (Schizoaffective Disorder)
01/2018
1Schizophrenia (Dementia Praecox)
01/2018
1Autoimmune Diseases of the Nervous System
01/2018

Drug/Important Bio-Agent (IBA)

1NDI-091143IBA
10/2022
1Sorafenib (BAY 43-9006)FDA Link
10/2022
1LipidsIBA
10/2022
1Caspase 3 (Caspase-3)IBA
01/2021
1Galectin 3 (LGALS3)IBA
01/2021
1CateninsIBA
01/2021
1Chitinase-3-Like Protein 1IBA
10/2020
1Ethacridine (Ethacridine Lactate)IBA
08/2019
1AutoantibodiesIBA
01/2018
1Polytetrafluoroethylene (Teflon)FDA Link
01/2018
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2018